West to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference
West Pharmaceutical Services (NYSE: WST) announced its participation in the 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ. The company will showcase its expertise on industry challenges and trends in packaging and containment for injectable drugs.
Atul Patel, VP of Delivery Devices at West, highlighted the growing importance of injectables in the biologic drug segment and the need for adapting drug delivery packaging and devices. West will share insights through various posters and a presentation on leveraging primary container and device platforms to reduce risk and accelerate time-to-market for combination products.
The event features a speaking session by Gurmeet Singh on Enabling High-Volume Drug Delivery with a Platform Approach. Additionally, West will present posters on topics such as pre-filled syringe system performance at low temperatures, container closure integrity testing, vial adapter transfer devices, and visual impairment affordances in drug delivery systems.
West Pharmaceutical Services (NYSE: WST) ha annunciato la sua partecipazione alla Conferenza 2024 PDA Universe of Pre-Filled Syringes and Injection Devices a Phoenix, AZ. L'azienda metterà in mostra la sua expertise sulle sfide e le tendenze del settore nel confezionamento e nella contenimento dei farmaci iniettabili.
Atul Patel, VP dei Dispositivi di Consegna presso West, ha sottolineato l'importanza crescente dei farmaci iniettabili nel segmento dei farmaci biologici e la necessità di adattare i packaging e i dispositivi per la somministrazione dei farmaci. West condividerà intuizioni attraverso vari poster e una presentazione su come sfruttare le piattaforme di contenitore primario e dispositivo per ridurre il rischio e accelerare il time-to-market per i prodotti combinati.
L'evento prevede una sessione di intervento di Gurmeet Singh su Abilitare la Consegna di Farmaci ad Alto Volume con un Approccio Piattaforma. Inoltre, West presenterà poster su argomenti come le performance dei sistemi di siringa pre-riempita a basse temperature, il test di integrità del contenitore, i dispositivi di trasferimento dell'adattatore del flacone e le agevolazioni per le disabilità visive nei sistemi di somministrazione dei farmaci.
West Pharmaceutical Services (NYSE: WST) anunció su participación en la Conferencia 2024 PDA Universe of Pre-Filled Syringes and Injection Devices en Phoenix, AZ. La empresa mostrará su experiencia sobre los desafíos y tendencias de la industria en el empaquetado y la contención de medicamentos inyectables.
Atul Patel, VP de Dispositivos de Entrega en West, destacó la creciente importancia de los inyectables en el segmento de medicamentos biológicos y la necesidad de adaptar el empaquetado y los dispositivos de entrega de medicamentos. West compartirá información a través de varios carteles y una presentación sobre cómo aprovechar las plataformas de contenedor primario y dispositivo para reducir el riesgo y acelerar el tiempo de comercialización de productos combinados.
El evento contará con una sesión de conferencias de Gurmeet Singh sobre Facilitando la Entrega de Medicamentos de Alto Volumen con un Enfoque de Plataforma. Además, West presentará carteles sobre temas como el rendimiento del sistema de jeringa precargada a bajas temperaturas, la prueba de integridad del cierre del contenedor, los dispositivos de transferencia del adaptador de vial y las adecuaciones para discapacidades visuales en los sistemas de entrega de medicamentos.
웨스트 제약 서비스 (NYSE: WST)는 애리조나주 피닉스에서 열리는 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference에 참여한다고 발표했습니다. 이 회사는 주사약물의 포장 및 보관에 대한 산업의 동향 및 과제를 선보일 것입니다.
웨스트의 배달 장치 부 vicepresident Atul Patel은 생물학적 약물 세그먼트에서 주사제의 중요성이 증가하고 있으며, 약물 전달 포장 및 장치를 조정할 필요성을 강조했습니다. 웨스트는 1차 용기 및 장치 플랫폼을 활용하여 리스크를 줄이고 복합 제품의 시장 출시 시간을 단축하는 방법에 대한 다양한 포스터와 발표를 공유할 것입니다.
이 행사에서는 Gurmeet Singh가 플랫폼 접근 방식을 통한 대량 약물 제공 가능성에 대한 발표를 합니다. 또한 웨스트는 저온에서의 프리필드 주사 시스템 성능, 용기 밀폐성 테스트, 바이알 어댑터 전송 장치 및 약물 전달 시스템의 시각 장애인용 배려와 같은 주제에 대한 포스터를 발표할 것입니다.
West Pharmaceutical Services (NYSE: WST) a annoncé sa participation à la Conférence 2024 PDA Universe of Pre-Filled Syringes and Injection Devices à Phoenix, en AZ. L'entreprise mettra en avant son expertise sur les défis et les tendances de l'industrie en matière d'emballage et de contenement pour les médicaments injectables.
Atul Patel, VP des Dispositifs de Livraison chez West, a souligné l'importance croissante des injectables dans le segment des médicaments biologiques et la nécessité d'adapter l'emballage et les dispositifs de livraison des médicaments. West partagera des informations via divers affiches et une présentation sur l'exploitation des plateformes de conteneurs primaires et de dispositifs pour réduire les risques et accélérer le délai de mise sur le marché des produits combinés.
L'événement comprend une session de discours par Gurmeet Singh sur Activer la Livraison de Médicaments en Grand Volume avec une Approche Plateforme. De plus, West présentera des affiches sur des sujets tels que la performance des systèmes de seringues pré-remplies à basse température, les tests d'intégrité des fermetures de conteneurs, les dispositifs de transfert d'adaptateurs de flacons et les aménagements pour les déficiences visuelles dans les systèmes de livraison de médicaments.
West Pharmaceutical Services (NYSE: WST) hat seine Teilnahme an der 2024 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Phoenix, AZ, bekannt gegeben. Das Unternehmen wird sein Fachwissen über die Herausforderungen und Trends der Branche im Bereich Verpackung und Kontainment für injizierbare Medikamente präsentieren.
Atul Patel, VP der Liefergeräte bei West, betonte die wachsende Bedeutung von Injektionspräparaten im Bereich der biologischen Arzneimittel und die Notwendigkeit, die Verpackung und Geräte für die Arzneimittelverabreichung anzupassen. West wird Einblicke durch verschiedene Poster und eine Präsentation zur Nutzung von Primärbehältern und Geräteplattformen zur Risikominderung und Beschleunigung der Markteinführungszeit von Kombinationsprodukten geben.
Die Veranstaltung beinhaltet eine Vortragssitzung von Gurmeet Singh über Ermöglichung einer Hochvolumen-Arzneimittelabgabe mit einem Plattformansatz. Darüber hinaus wird West Poster zu Themen wie der Leistung von vorgefüllten Spritzensystemen bei niedrigen Temperaturen, Tests der Behälterverschlussintegrität, Vial-Adapter-Transfergeräten und den Erleichterungen für Sehbehinderte in Arzneimittelverabreichungssystemen präsentieren.
- None.
- None.
"With the rise of biologic drugs, injectables are the fastest growing drug segment today, bringing with it new challenges of complex molecules and treatment requirements," says Atul Patel, Vice President, Delivery Devices at West. "As the market leader, West continues to adapt and expand the performance of high-quality drug delivery packaging and devices to meet the changing needs of patients, regulators, and industry partners."
At this year's PDA, West will be sharing insights through various posters and a presentation on how leveraging primary container and device platforms can reduce risk and accelerate time-to-market for combination products.
Featured Speaking Session:
Title: Enabling High-Volume Drug Delivery with a Platform Approach
Speaker: Gurmeet Singh, Senior Director, Business Development
Date and Time: October 22, 2024, 10:25- 10:35am PST
Featured Posters:
Title: Performance of Pre-Filled Syringe Systems at Low Temperature
Author: Page McAndrew, Director, Scientific Communications
Title: Container Closure Integrity Testing Strategy for Drug-led Combination Products: A Practical Approach
Author: Jen Roark, Technology Manager, Scientific Affairs
Title: Evaluating Vial Adapter Transfer Devices for Reconstitution with Pre-Filled Syringes: Using USP (United States Pharmacopoeia) <382>
Author: Ronan Jenkinson, Manager, Sales Business and Development, Combination Product and Services
Title: Visual Impairment Affordances Can Benefit All Users
Author: Lisa Lacouette-Ward, Senior Specialist, Regulatory Affairs
For more information about the PDA Universe of Pre-Filled Syringes and Injection Devices Conference, please visit: PDA Universe of Pre-Filled Syringes and Injection Devices Conference 2024 | PDA
About West
West Pharmaceutical Services, Inc. is a leading provider of innovative, high-quality injectable solutions and services. As a trusted partner to established and emerging drug developers, West helps ensure the safe, effective containment and delivery of life-saving and life-enhancing medicines for patients. With over 10,000 team members across 50 sites worldwide, West helps support our customers by delivering approximately 43 billion components and devices each year.
Headquartered in
View original content to download multimedia:https://www.prnewswire.com/news-releases/west-to-present-on-large-volume-delivery-systems-administration-and-transfer-devices-and-prefillable-syringe-component-expertise-at-the-pda-conference-302282228.html
SOURCE West Pharmaceutical Services, Inc.
FAQ
What is West Pharmaceutical Services presenting at the 2024 PDA Conference?
When and where is West's featured speaking session at the 2024 PDA Conference?
What topics are covered in West's poster presentations at the 2024 PDA Conference?
Why is West Pharmaceutical Services (WST) focusing on injectable drug delivery solutions?
